ITGAM / CD11b

CD11b antibody LS-C46272 is a biotin-conjugated mouse monoclonal antibody to human CD11b (ITGAM). Validated for Flow and IP.

Antibodies Primary

Article No

LS-C46272-0.1

Species Reactivity

human

Size

0.1 mg

Clone

MEM-174

Source / Host

mouse

Shipping Information

RT

Application

FC, IP

Article No

LS-C46272-0.1

Species Reactivity

human

Size

0.1 mg

Clone

MEM-174

Source / Host

mouse

Shipping Information

RT

Application

FC, IP

Specifications

NCBI Number 3684
Application FC, IP
Article No LS-C46272-0.1
Country Availability SE, FI, DK, NO, FO, GL
Clone MEM-174
Clone Type monoclonal
Concentration 1 mg/ml
Conjugation Biotin
Description CD11b antibody LS-C46272 is a biotin-conjugated mouse monoclonal antibody to human CD11b (ITGAM). Validated for Flow and IP.
Recommended Dilution FC (1:400)
Supplier LifeSpan Biosciences
Entrez Gene ID 3684
Gene Symbol ITGAM
Immunogen Human granulocytes.
Isotype IgG2a
Notes CD11b antibody LS-C46272 is a biotin-conjugated mouse monoclonal antibody to human CD11b (ITGAM). Validated for Flow and IP.
Alias Names ITGAM, Antigen CD11b (p170), CD11B, CD11b antigen, CR3A, Integrin alpha-M, MAC-1, MO1A, Neutrophil adherence receptor, MAC1A, SLEB6, CR-3 alpha chain
Product Type Antibodies Primary
Protocol Suggested working dilution is 1:400. Indicated dilution is recommended starting point for use of this product. Working concentrations should be determined by the investigator.
Purification Protein G purified
Shipping Information RT
Size 0.1 mg
Source / Host mouse
Species Reactivity human
Storage 4°C
Substrate / Buffer PBS, pH 7.4, 15 mM Sodium Azide
Technical Specifications The antibody MEM-174 recognizes CD11b antigen (Mac-1 alpha), a 165-170 kDa type I transmembrane protein mainly expressed on monocytes, granulocytes and NK-cells. The CD11b mediates neutrophil and monocyte interactions with stimulated endothelium.
Product Page Updated 2024-04-12T09:51:03.289Z

Documentation

Shipping info
The delivery time for this item is approximately 9-18 business days. Read more